NEW YORK (GenomeWeb News) - Simulations Plus said on Friday that the US Food and Drug Administration has licensed its ADMET Predictor software for use in its Cardiovascular and Renal Products division.
ADMET Predictor predicts approximately 80 properties of molecules, including physicochemical, biopharmaceutical, metabolism, toxicity, and some activity properties, based on their molecular structure.
Financial terms of the agreement were not disclosed.